Sign In
Buy GLTO
$22.20
+0 (+0%)
At Close: Jun 18, 2026
What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?
01:00pm, Monday, 20'th Apr 2026
Does Galecto, Inc. (DMRA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Galecto, Inc. (NASDAQ:GLTO) Given Consensus Recommendation of “Moderate Buy” by Brokerages
04:14am, Wednesday, 04'th Mar 2026
Shares of Galecto, Inc. (NASDAQ: GLTO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six analysts that are currently covering the company, MarketBeat.com reports. One r
Galecto, Inc. (NASDAQ:GLTO) Short Interest Up 86.6% in February
03:00am, Monday, 02'nd Mar 2026
Galecto, Inc. (NASDAQ: GLTO - Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 277,004 shares
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with b
Galecto Announces Pricing of $275 Million Underwritten Public Offering
10:42pm, Tuesday, 10'th Feb 2026
BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with b
Galecto, Inc. (NASDAQ:GLTO) Given Average Rating of “Moderate Buy” by Analysts
05:44am, Sunday, 18'th Jan 2026
Shares of Galecto, Inc. (NASDAQ: GLTO - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five ratings firms that are presently covering the company, MarketBeat Rating
Analysts Set Galecto, Inc. (NASDAQ:GLTO) PT at $41.00
01:06am, Friday, 16'th Jan 2026
Galecto, Inc. (NASDAQ: GLTO - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five analysts that are covering the firm, MarketBeat.com reports. One research analyst ha
Comparing Galecto (NASDAQ:GLTO) and Avidity Biosciences (NASDAQ:RNA)
02:10am, Sunday, 04'th Jan 2026
Avidity Biosciences (NASDAQ: RNA - Get Free Report) and Galecto (NASDAQ: GLTO - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies base
Galecto (NASDAQ:GLTO) Shares Down 13.3% – Time to Sell?
02:13am, Tuesday, 30'th Dec 2025
Galecto, Inc. (NASDAQ: GLTO - Get Free Report)'s stock price dropped 13.3% on Monday. The stock traded as low as $29.61 and last traded at $29.61. Approximately 82,189 shares changed hands during trad
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Tuesday, 16'th Dec 2025
BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (the “Company” or “Galecto”) (Nasdaq: GLTO) today announced that the Company's Board of Directors approved the grant of non-qualified st
GLTO, MOVE: two penny stocks quadrupled today – but should you buy?
01:08pm, Monday, 10'th Nov 2025
Two obscure US biotech and medtech names – Galecto Inc (NASDAQ: GLTO) and Movano Inc (NASDAQ: MOVE) – stunned markets today with explosive rallies, each surging roughly 300%. While the gains were
Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029
11:47am, Monday, 10'th Nov 2025
Galecto Inc. (NASDAQ:GLTO) stock tripled on Monday, with a session volume of 23.26 million, compared to the average volume of 2.41 million, as per data from Benzinga Pro.
Galecto Announces Acquisition of Damora Therapeutics
07:00am, Monday, 10'th Nov 2025
Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproli
Galecto Reports Third Quarter 2025 Operating and Financial Results
04:30pm, Thursday, 06'th Nov 2025
BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today ann
What's Going On With Nano-Cap Galecto Stock On Tuesday?
01:05pm, Tuesday, 07'th Oct 2025
Galecto Inc. (NASDAQ:GLTO) stock spiked on Tuesday, with a session volume of 61.11 million, compared to the average volume of 984,320, as per data from Benzinga Pro.
